KeyCorp director disposes 750 shares, adds 1,453 deferred shares
KeyCorp director reports share disposition and deferral of fees into stock-based compensation plan.
Rhea-AI Filing Summary
KeyCorp director reports share disposition and deferral of fees into stock-based compensation plan. A KeyCorp director reported a transaction dated 12/31/2025 involving 750 common shares disposed of. The director also acquired 1,453 deferred share units at a reference price of $20.64, each economically equivalent to a KeyCorp common share, under the company’s Amended and Restated Directors' Deferred Share Sub-Plan to the 2019 Equity Compensation Plan.
Following these transactions, the director beneficially owned 76,711 derivative securities in the form of deferred shares. Payment of these deferred shares has been postponed until the earlier of January 1, 2027, or the director’s death, and this total includes approximately 747 dividend-equivalent deferred shares accrued in December 2025.
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Deferred Shares | 1,453 | $20.64 | $30K |
| holding | Common Shares | -- | -- | -- |
Footnotes (3)
- F1. Directors may elect to defer the payment of directors' fees into the Amended and Restated Directors' Deferred Share Sub-Plan to the KeyCorp Amended and Restated 2019 Equity Compensation Plan (the "Deferred Share Plan"). The deferred fees are converted into deferred shares, which are the economic equivalent of common shares.
- F2. Under the terms of the Deferred Share Plan, payment of the deferred shares has been deferred until the earlier of January 1, 2027, or the death of the participant.
- F3. Includes approximately 747 dividend-equivalent deferred shares accrued under the Deferred Share Plan in December 2025.
AI-generated analysis. How Rhea-AI works. Not financial advice.